These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Frydman A Haemostasis; 1996; 26 Suppl 2():24-38. PubMed ID: 8707165 [TBL] [Abstract][Full Text] [Related]
7. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins. Jeske WP; Walenga JM; Hoppensteadt DA; Vandenberg C; Brubaker A; Adiguzel C; Bakhos M; Fareed J Semin Thromb Hemost; 2008 Feb; 34(1):74-85. PubMed ID: 18393144 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers. Eriksson BI; Söderberg K; Widlund L; Wandeli B; Tengborn L; Risberg B Thromb Haemost; 1995 Mar; 73(3):398-401. PubMed ID: 7667822 [TBL] [Abstract][Full Text] [Related]
15. An update on heparins at the beginning of the new millennium. Fareed J; Hoppensteadt DA; Bick RL Semin Thromb Hemost; 2000; 26 Suppl 1():5-21. PubMed ID: 11011802 [TBL] [Abstract][Full Text] [Related]
16. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Hirsh J; Raschke R Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472 [TBL] [Abstract][Full Text] [Related]
17. Heparin and low molecular weight heparin: background and pharmacology. Morris TA Clin Chest Med; 2003 Mar; 24(1):39-47. PubMed ID: 12685055 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of low molecular weight heparins. Bara L; Samama M Acta Chir Scand Suppl; 1988; 543():65-72. PubMed ID: 2847460 [TBL] [Abstract][Full Text] [Related]